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ABSTRACT
Streptococcus pyogenes (group A streptococcus; GAS) is a Gram-positive bacterium that
causes invasive and non invasive infections in human skin and mucosal tissue. Since the
mid-1980s, a conspicuous increase in the incidence and severity of invasive infections
caused by GAS has been observed worldwide. S. pyogenes infections are endemic
amongst many Aboriginal communities of Northern Australia. With rates of infection in
these communities being amongst the highest in the world, there is an urgent need for
identifying the key virulence factors involved in the initiation and progression of invasive
GAS diseases. Streptokinase, a secreted group A streptococcal protein, activates host
plasminogen converting it to the broad spectrum protease plasmin. Several plasmin(ogen)
binding receptors present on the GAS cell surface facilitate the acquisition of cell surface
plasmin activity. The gene encoding encoding streptokinase (ska) is present in all GAS
isolates. In this study, allelic variants of ska have been characterised in various GAS
isolates from the Northern Territory of Australia. The region encoding the ß domain of
ska in these isolates was sequenced and phylogenetically analysed to identify the specific
allelic variant genotype for each isolate. Culture supernatants of these strains were
examined for the presence of streptokinase and the cysteine protease, SpeB, via
immunoblotting using rabbit polyclonal antisera directed against these proteins. Two
GAS strains (ALAB49 and 5448) and their isogenic ska and speB mutants were used to
demonstrate the specificity and applicability of this technique for detecting the presence
of streptokinase and SpeB in the culture supernatants. Using this methodology,
streptokinase expression in culture supernatants of NT GAS isolates was investigated.
Streptokinase was found to be expressed in mid-log, late-log and early stationary growth
phases for all NT isolates examined in this study. It was also found that different ska
alleles expressed streptokinase proteins of variable molecular weights. The streptokinase
iv

expressed by strains possessing alleles of ska 1 cluster (NS53, NS730 and NS931) and
strains possessing alleles of ska 2a sub-cluster (NS696, 5448) express a 48 kDa
streptokinase protein and strains possessing alleles of the ska 2b sub-cluster (NS13,
ALAB49, NS88.2 and NS455) express a 50 kDa streptokinase protein. Culture
supernatants from all GAS strains in early stationary growth phase were found to contain
pro-SpeB (inactive precursor). Mature SpeB was only detected in the early stationary
phase culture supernatants of strain NS53. Examples of the three known allelic ska
variants were cloned from strains NS931, 5448 and ALAB49. DNA sequence analysis of
these clones showed a high percentage of identity with previously published ska
sequences. The recombinant plasmid pSka1 (containing the ska insert from NS931) was
expressed and purified. The yield of the purified protein obtained was 1.16 mg/ml. Future
work will determine the functional differences between the recombinant proteins
expressed by these clones and it is hoped that this will help gain a better understanding of
the role of the allelic variation of streptokinase in GAS disease virulence.
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